Torigen Pharmaceuticals

About:

Torigen Pharmaceuticals focuses on providing cancer care solutions for animals.

Top Investors: Propel(X), Gaingels, University of Notre Dame, Connecticut Innovations, Everywhere Ventures

Description:

Torigen Pharmaceuticals focuses on providing cancer care solutions for animals. They strive to bring novel approaches to the market to tackle companion animal cancers, building on years of existing scientific research and pushing the boundaries of innovation. The company was founded in 2013 by Ashley Kalinauskas and Mark Suckow and is based in Farmington, Connecticut, United States.

Total Funding Amount:

$16.1M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Farmington, Connecticut, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)torigen.com

Founders:

Ashley Kalinauskas, Mark Suckow

Number of Employees:

11-50

Last Funding Date:

2022-11-16

IPO Status:

Private

Industries: